BioSpace News Archive

Xenetic Biosciences, Inc. today announced that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present at the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023 in New York, NY and virtually.

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will participate in an upcoming investor conference in September.

Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that Daniel J. O’Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview and participate in one-on-one meetings at the Baird Global Healthcare Conference and the Morgan Stanley 21st Annual Global Healthcare Conference, both being held in New York, NY.

Eterna Therapeutics Inc. today announced the appointment of Dorothy Clarke to its Board of Directors.

Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Wednesday, September 20, 2023, between 8:30 a.m. and 1:00 p.m. ET.

Travere Therapeutics, Inc. and Mirum Pharmaceuticals, Inc. announced the completion of the previously announced sale of Travere’s bile acid product portfolio that includes Cholbam® and Chenodal®, two medications addressing rare diseases in high-need settings.

Avenue Therapeutics, Inc. today announced that Alexandra MacLean, M.D., Chief Executive Officer, will present a corporate update at the H.C. Wainwright 25th Annual Global Investment Conference scheduled to take place September 11-13, 2023.

YS Biopharma Co., Ltd. today announced that it will participate in in Citi’s 18th Annual Biopharma Conference from Tuesday, September 5 to Thursday, September 7, 2023.

The occurrence of neurological adverse events following COVID vaccines is generally acknowledged, but their significance is downplayed, writes Jane Orient, M.D., in the fall issue of the Journal of American Physicians and Surgeons.

Acupath Labs released a white paper highlighting the impressive results of a large-scale internal study analyzing the clinical utility of its Acu-UR017 bladder cancer biomarker.